Norbel Group CbCP 2025-12-31 Norbel Group CbCP 2025-01-012025-12-31 Norbel Group CbCP 2025-01-012025-12-31 Germany Norbel Group CbCP 2025-12-31 Germany Norbel Group CbCP 2025-01-012025-12-31 Spain Norbel Group CbCP 2025-12-31 Spain Norbel Group CbCP 2025-01-012025-12-31 France Norbel Group CbCP 2025-12-31 France Norbel Group CbCP 2025-01-012025-12-31 Italy Norbel Group CbCP 2025-12-31 Italy Norbel Group CbCP 2025-01-012025-12-31 Poland Norbel Group CbCP 2025-12-31 Poland Norbel Group CbCP 2025-01-012025-12-31 Portugal Norbel Group CbCP 2025-12-31 Portugal Norbel Group CbCP 2025-01-012025-12-31 United Kingdom Norbel Group CbCP 2025-12-31 United Kingdom Norbel Group CbCP 2025-01-012025-12-31 Switzerland Norbel Group CbCP 2025-12-31 Switzerland Norbel Group CbCP 2025-01-012025-12-31 Austria Norbel Group CbCP 2025-12-31 Austria iso4217:EUR xbrli:pure

Public Country by Country Report (on income tax information)

Section 1. General information

Name of ultimate parent of group / of standalone companyNorbel Inversiones, S.L.
Country of registered office of ultimate parent undertakingThe Kingdom of Spain
Date of start of financial year2025-01-01
Date of end of financial year2025-12-31
Reporting currencyEUR
Application of option to report in accordance with taxation reporting instructionsYes
Name and registered office of a single subsidiary undertaking which has published the report on income tax information of an undertaking that is not governed by the law of a Member State-
Name and address of a single branch which has published the report on income tax information of an undertaking that is not governed by the law of a Member State-
Language of reportenglish - en

Section 2. Overview of information on a country-by-country basis

Name of Member State or tax jurisdiction Country code of Member State or tax jurisdiction Revenues Profit (loss) before tax Income tax paid (on cash basis) Income tax accrued – current year Accumulated earnings Number of employees
Germany DE 44715701 1071537 230139 -315006 -2239078 50
Spain ES 1134620394 186981376 42210810 -42081148 -915081628 2129
France FR 11459145 276321 0 -90911 -714681 5
Italy IT 35118631 883187 1322421 -592500 -2139238 44
Poland PL 9 -139932 0 -4 1110263 0
Portugal PT 10515601 573811 141026 -210168 659725 17
United Kingdom GB 12499534 53456 141971 -14122 -421409 2
Switzerland CH 52685 -30416 0 0 112062 0
Austria AT 1622886 42113 14229 -9673 -49213 4
All other tax jurisdictions (aggregated basis)
- - - - - -

Section 3. List of subsidiaries and activities

Name of Member State or tax jurisdictionCountry code of Member State or tax jurisdictionName of subsidiary undertakings consolidated in financial statements of ultimate parent undertakingBrief description per country of nature of activities in Member State or tax jurisdiction
Germany DE Bertex Pharma GmbH Sales, marketing or distribution of pharmaceutical products
Austria AT Rovi, GmbH EP Austria Sales, marketing or distribution of pharmaceutical products
Spain ES Norbel Inversiones, S.L. Ownership of shares or other instruments representing equity
Spain ES Norba Inversiones, S.L.U. Provision of services and Other
Spain ES Lobelvia Inversiones, S.L. Provision of services - property rental
Spain ES Residencia Burja, S.L. Provision of services - Property management and administration
Spain ES La Parra del Soberal, S.L. Agricultural and livestock production
Spain ES R.U. Status El Carmen, S.L. Provision of services - Other accommodation services
Spain ES Laboratorios Farmacéuticos Rovi, S.A. Manufacture of pharmaceutical specialities.
Spain ES Pan Química Farmacéutica, S.A. Manufacture of pharmaceutical specialities.
Spain ES Gineladius, S.L. Sales, marketing or distribution of medical products
Spain ES Rovi Pharma Industrial Services, S.A.U. Manufacture of pharmaceutical specialities.
Spain ES Rovi Escúzar, S.L Manufacture of pharmaceutical specialities.
Spain ES Gades Provision of services - Property management and administration
Spain ES Glicopepton Biotech, S.L. Manufacture of pharmaceutical specialities.
Spain ES Cells IA Tecnologies Computer programming activities
France FR Rovi, S.A.S. Sales, marketing or distribution of pharmaceutical products
Italy IT Rovi Biotech, S.r.l Sales, marketing or distribution of pharmaceutical products
Poland PL Rovi Biotech sp.z.o.o. Sales, marketing or distribution of pharmaceutical products
Poland PL Laboratorios Farmacéuticos Rovi, S.A. EP Polonia Sales, marketing or distribution of pharmaceutical products
Portugal PT Laboratorios Farmacéuticos Rovi, S.A. EP Portugal Sales, marketing or distribution of pharmaceutical products
United Kingdom GB Rovi Biotech Limited Sales, marketing or distribution of pharmaceutical products
Germany DE Rovi, GmbH Sales, marketing or distribution of pharmaceutical products
Switzerland CH Rovi Biotech GmbH Sales, marketing or distribution of pharmaceutical products

Section 4. Omitted information

Information omitted (if any) for this financial year
Information omittedInformation omitted, other tax jurisdictionsExplanation of reason for omission of information
Disclosure of information omitted for previous financial years

Section 5. Explanations for material discrepancies between income tax paid and accrued

Explanation of any material discrepancies between income tax paid and accrued

Conclusion